An Exploratory Clinical Study Evaluating the Safety and Efficacy of Intravenous Anti-CD20/CD30-CAR-T Cell Infusion in Relapsed/Refractory Lymphoma Patients.
Clinical trial NCT06519344 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06519344
- Sponsor
- Shanghai Tongji Hospital, Tongji University School of Medicine
- Status
- NOT_YET_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-31
- Primary completion
- 2026-07-30
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.